Show simple item record

dc.contributor.authorCutts, E
dc.contributor.authorTaylor, G
dc.contributor.authorPardo, M
dc.contributor.authorYu, L
dc.contributor.authorWills, J
dc.contributor.authorChoudhary, J
dc.contributor.authorVannini, A
dc.contributor.authorWood, A
dc.date.accessioned2021-03-30T13:46:31Z
dc.date.available2021-03-30T13:46:31Z
dc.date.issued2021-01-13
dc.identifier.citation2021
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/4463
dc.identifier.doi10.12688/wellcomeopenres.16482.1
dc.description.abstractCondensin complexes compact and disentangle chromosomes in preparation for cell division. Commercially available antibodies raised against condensin subunits have been widely used to characterise their cellular interactome. Here we have assessed the specificity of a polyclonal antibody (Bethyl A302-276A) that is commonly used as a probe for NCAPH2, the kleisin subunit of condensin II, in mammalian cells. We find that, in addition to its intended target, this antibody cross-reacts with one or more components of the SWI/SNF family of chromatin remodelling complexes in an NCAPH2-independent manner. This cross-reactivity, with an abundant chromatin-associated factor, is likely to affect the interpretation of protein and chromatin immunoprecipitation experiments that make use of this antibody probe.
dc.languageeng
dc.language.isoeng
dc.rights.urihttps://creativecommons.org/licenses/by/4.0
dc.titleA commercial antibody to the human condensin II subunit NCAPH2 cross-reacts with a SWI/SNF complex component
dc.typeJournal Article
dcterms.dateAccepted2020-12-23
rioxxterms.versionVoR
rioxxterms.versionofrecord10.12688/wellcomeopenres.16482.1
rioxxterms.licenseref.urihttps://creativecommons.org/licenses/by/4.0
rioxxterms.licenseref.startdate2021-01-13
rioxxterms.typeJournal Article/Review
pubs.notesNot known
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Biology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Biology/Functional Proteomics Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Structural Biology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Structural Biology/Vannini Group
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Biology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Biology/Functional Proteomics Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Structural Biology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Structural Biology/Vannini Group
pubs.publication-statusPublished
pubs.embargo.termsNot known
icr.researchteamFunctional Proteomics Group
icr.researchteamVannini Group
icr.researchteamFunctional Proteomics Groupen_US
icr.researchteamVannini Groupen_US
dc.contributor.icrauthorPardo Calvo, Maria Mercedes
dc.contributor.icrauthorVannini, Alessandro


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record

https://creativecommons.org/licenses/by/4.0
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/4.0